VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 4,946

Sort by:

2020 COVID 19 Drug Pipeline Report- Current Status, Phase, Companies, Pre-Clinical And Clinical Drugs US$ 2,899.00

The 2020 COVID-19 pipeline report presents a comprehensive overview of the research and development of COVID drug candidates. It presents drugs in development that could potentially reach the market i...

March 2020 80 pages

2020 Alcohol Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Alcohol Addiction pipeline report presents a comprehensive overview of the research and development of Alcohol Addiction drug candidates. It presents drugs in development that could potential...

February 2020 133 pages

2020 Anesthetic Effect Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Anesthetic Effect pipeline report presents a comprehensive overview of the research and development of Anesthetic Effect drug candidates. It presents drugs in development that could potential...

February 2020 88 pages

2020 Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Attention Deficit Hyperactivity Disorder (ADHD) pipeline report presents a comprehensive overview of the research and development of Attention Deficit Hyperactivity Disorder (ADHD) drug candi...

February 2020 155 pages

2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Autism spectrum disorders (ASD) pipeline report presents a comprehensive overview of the research and development of Autism spectrum disorders (ASD) drug candidates. It presents drugs in deve...

February 2020 127 pages

2020 Batten Disease Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Batten Disease pipeline report presents a comprehensive overview of the research and development of Batten Disease drug candidates. It presents drugs in development that could potentially rea...

February 2020 82 pages

2020 Binge Eating Disorder Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Binge Eating Disorder pipeline report presents a comprehensive overview of the research and development of Binge Eating Disorder drug candidates. It presents drugs in development that could p...

February 2020 55 pages

2020 Canavan Disease Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Canavan Disease pipeline report presents a comprehensive overview of the research and development of Canavan Disease drug candidates. It presents drugs in development that could potentially r...

February 2020 31 pages

2020 Cancer Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Cancer Pain pipeline report presents a comprehensive overview of the research and development of Cancer Pain drug candidates. It presents drugs in development that could potentially reach the...

February 2020 132 pages

2020 Cerebral Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Cerebral Palsy pipeline report presents a comprehensive overview of the research and development of Cerebral Palsy drug candidates. It presents drugs in development that could potentially rea...

February 2020 46 pages

2020 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline report presents a comprehensive overview of the research and development of Chronic Inflammatory Demyelinating Polyneuropathy...

February 2020 51 pages

2020 Cluster Headache Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Cluster Headache pipeline report presents a comprehensive overview of the research and development of Cluster Headache drug candidates. It presents drugs in development that could potentially...

February 2020 42 pages

2020 Cognitive Impairment Associated With Schizophrenia (CIAS) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline report presents a comprehensive overview of the research and development of Cognitive Impairment Associated With Schizophren...

February 2020 87 pages

2020 Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) pipeline report presents a comprehensive overview of the research and development of Complex Regional Pain Syndrome (Reflex Sympa...

February 2020 51 pages

2020 Dental Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Dental Pain pipeline report presents a comprehensive overview of the research and development of Dental Pain drug candidates. It presents drugs in development that could potentially reach the...

February 2020 36 pages

2020 Drug Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Drug Addiction pipeline report presents a comprehensive overview of the research and development of Drug Addiction drug candidates. It presents drugs in development that could potentially rea...

February 2020 169 pages

2020 Encephalitis Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Encephalitis pipeline report presents a comprehensive overview of the research and development of Encephalitis drug candidates. It presents drugs in development that could potentially reach t...

February 2020 47 pages

2020 Encephalomyelitis Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Encephalomyelitis pipeline report presents a comprehensive overview of the research and development of Encephalomyelitis drug candidates. It presents drugs in development that could potential...

February 2020 51 pages

2020 Fatigue Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Fatigue pipeline report presents a comprehensive overview of the research and development of Fatigue drug candidates. It presents drugs in development that could potentially reach the market...

February 2020 42 pages

2020 Fibromyalgia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Fibromyalgia pipeline report presents a comprehensive overview of the research and development of Fibromyalgia drug candidates. It presents drugs in development that could potentially reach t...

February 2020 76 pages

2020 Friedreich Ataxia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Friedreich Ataxia pipeline report presents a comprehensive overview of the research and development of Friedreich Ataxia drug candidates. It presents drugs in development that could potential...

February 2020 102 pages

2020 Globoid Cell Leukodystrophy (Krabbe Disease) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Globoid Cell Leukodystrophy (Krabbe Disease) pipeline report presents a comprehensive overview of the research and development of Globoid Cell Leukodystrophy (Krabbe Disease) drug candidates....

February 2020 52 pages

2020 Guillain-Barre Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Guillain-Barre Syndrome pipeline report presents a comprehensive overview of the research and development of Guillain-Barre Syndrome drug candidates. It presents drugs in development that cou...

February 2020 46 pages

2020 Hyperalgesia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Hyperalgesia pipeline report presents a comprehensive overview of the research and development of Hyperalgesia drug candidates. It presents drugs in development that could potentially reach t...

February 2020 34 pages

2020 Insomnia (Sleep Deprivation) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Insomnia (Sleep Deprivation) pipeline report presents a comprehensive overview of the research and development of Insomnia (Sleep Deprivation) drug candidates. It presents drugs in developmen...

February 2020 107 pages

2020 Interstitial Cystitis (Painful Bladder Syndrome) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Interstitial Cystitis (Painful Bladder Syndrome) pipeline report presents a comprehensive overview of the research and development of Interstitial Cystitis (Painful Bladder Syndrome) drug can...

February 2020 71 pages

2020 Low Back Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Low Back Pain pipeline report presents a comprehensive overview of the research and development of Low Back Pain drug candidates. It presents drugs in development that could potentially reach...

February 2020 104 pages

2020 Metachromatic Leukodystrophy (MLD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Metachromatic Leukodystrophy (MLD) pipeline report presents a comprehensive overview of the research and development of Metachromatic Leukodystrophy (MLD) drug candidates. It presents drugs i...

February 2020 54 pages

2020 Mild Cognitive Impairment (MCI) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Mild Cognitive Impairment (MCI) pipeline report presents a comprehensive overview of the research and development of Mild Cognitive Impairment (MCI) drug candidates. It presents drugs in deve...

February 2020 94 pages

2020 Multiple System Atrophy (MSA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Multiple System Atrophy (MSA) pipeline report presents a comprehensive overview of the research and development of Multiple System Atrophy (MSA) drug candidates. It presents drugs in developm...

February 2020 78 pages

2020 Narcolepsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Narcolepsy pipeline report presents a comprehensive overview of the research and development of Narcolepsy drug candidates. It presents drugs in development that could potentially reach the m...

February 2020 82 pages

2020 Neuromyelitis Optica (Devic's Syndrome) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Neuromyelitis Optica (Devic's Syndrome) pipeline report presents a comprehensive overview of the research and development of Neuromyelitis Optica (Devic's Syndrome) drug candidates. It presen...

February 2020 112 pages

2020 Nicotine Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Nicotine Addiction pipeline report presents a comprehensive overview of the research and development of Nicotine Addiction drug candidates. It presents drugs in development that could potenti...

February 2020 78 pages

2020 Obsessive Compulsive Disorder (OCD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Obsessive Compulsive Disorder (OCD) pipeline report presents a comprehensive overview of the research and development of Obsessive Compulsive Disorder (OCD) drug candidates. It presents drugs...

February 2020 51 pages

2020 Opioid Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Opioid Addiction pipeline report presents a comprehensive overview of the research and development of Opioid Addiction drug candidates. It presents drugs in development that could potentially...

February 2020 132 pages

2020 Post-Traumatic Stress Disorder (PTSD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Post-Traumatic Stress Disorder (PTSD) pipeline report presents a comprehensive overview of the research and development of Post-Traumatic Stress Disorder (PTSD) drug candidates. It presents d...

February 2020 133 pages

2020 Progressive Supranuclear Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Progressive Supranuclear Palsy pipeline report presents a comprehensive overview of the research and development of Progressive Supranuclear Palsy drug candidates. It presents drugs in develo...

February 2020 82 pages

2020 Restless Legs Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Restless Legs Syndrome pipeline report presents a comprehensive overview of the research and development of Restless Legs Syndrome drug candidates. It presents drugs in development that could...

February 2020 56 pages

2020 Rett Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Rett Syndrome pipeline report presents a comprehensive overview of the research and development of Rett Syndrome drug candidates. It presents drugs in development that could potentially reach...

February 2020 106 pages

2020 Sedation Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Sedation pipeline report presents a comprehensive overview of the research and development of Sedation drug candidates. It presents drugs in development that could potentially reach the marke...

February 2020 46 pages

2020 Spinal Muscular Atrophy (SMA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Spinal Muscular Atrophy (SMA) pipeline report presents a comprehensive overview of the research and development of Spinal Muscular Atrophy (SMA) drug candidates. It presents drugs in developm...

February 2020 116 pages

2020 Tourette Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Tourette Syndrome pipeline report presents a comprehensive overview of the research and development of Tourette Syndrome drug candidates. It presents drugs in development that could potential...

February 2020 56 pages

2020 Trigeminal Neuralgia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs US$ 1,999.00

The 2020 Trigeminal Neuralgia pipeline report presents a comprehensive overview of the research and development of Trigeminal Neuralgia drug candidates. It presents drugs in development that could pot...

February 2020 51 pages

Acinetobacter Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Acinetobacter Infections Drug pipeline report- 2020 is an annual R&D review of Acinetobacter Infections pipeline candidates. The report presents the current status of all major Acinetobacter Infection...

October 2019 150 pages

African Trypanosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

African Trypanosomiasis Drug pipeline report- 2020 is an annual R&D review of African Trypanosomiasis pipeline candidates. The report presents the current status of all major African Trypanosomiasis t...

October 2019 40 pages

Anthrax Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Anthrax Drug pipeline report- 2020 is an annual R&D review of Anthrax pipeline candidates. The report presents the current status of all major Anthrax therapeutic compounds. Detailed insights into Ant...

October 2019 70 pages

Aspergillosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Aspergillosis Drug pipeline report- 2020 is an annual R&D review of Aspergillosis pipeline candidates. The report presents the current status of all major Aspergillosis therapeutic compounds. Detailed...

October 2019 80 pages

Bacillary Dysentery (Shigellosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Bacillary Dysentery (Shigellosis) Drug pipeline report- 2020 is an annual R&D review of Bacillary Dysentery (Shigellosis) pipeline candidates. The report presents the current status of all major Bacil...

October 2019 40 pages

Bacterial Vaginosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Bacterial Vaginosis Drug pipeline report- 2020 is an annual R&D review of Bacterial Vaginosis pipeline candidates. The report presents the current status of all major Bacterial Vaginosis therapeutic c...

October 2019 50 pages

Botulism Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Botulism Drug pipeline report- 2020 is an annual R&D review of Botulism pipeline candidates. The report presents the current status of all major Botulism therapeutic compounds. Detailed insights into...

October 2019 40 pages